Concepedia

Mally Romero

MR

Statistics

Publications

6

Citations

865

H-Index

6

Active since

2003

Affiliations

Translational Research in Oncology(Current)

Genentech

Mally Romero is an author at Translational Research in Oncology specializing in pharmacology, pharmacy, and molecular oncology.

Publications per year

2003–2014

6

Publications

6

Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101.

Jane A. Plumb, Paul W. Finn, Robert J. Williams et al. · PubMed · 2003 · 313 citations

, , +15

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

Mark Merchant, Xiaolei Ma, Henry R. Maun et al. · Proceedings of the National Academy of Sciences · 2013 · 243 citations · Full text

, , +17

MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival

Renhui Yang, Zhong Zheng, Mally Romero et al. · Cancer Research · 2008 · 208 citations

, , +13

<scp>PAK1</scp> mediates pancreatic cancer cell migration and resistance to <scp>MET</scp> inhibition

Wei Zhou, Adrian M. Jubb, Karen S. Lyle et al. · The Journal of Pathology · 2014 · 54 citations · Full text

, , +17

Onartuzumab (MetMAb): Using Nonclinical Pharmacokinetic and Concentration–Effect Data to Support Clinical Development

Hong Xiang, Brendan C. Bender, Arthur E. Reyes et al. · Clinical Cancer Research · 2013 · 35 citations · Full text

, , +17

1–5 of 6